Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LifeMD, Inc. Director's Dealing 2019

Nov 13, 2019

33298_dirs_2019-11-13_5229afc1-2a2e-4baa-af43-ce02b2fbccaa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2019-11-08

Reporting Person: Walters Happy David (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-11-08 Common Stock, par value $0.01 P 51500 $0.1860 Acquired 276500 Direct
2019-11-08 Common Stock, par value $0.01 P 45500 $0.1750 Acquired 322000 Direct
2019-11-08 Common Stock, par value $0.01 P 38000 $0.1840 Acquired 360000 Direct
2019-11-08 Common Stock, par value $0.01 P 15200 $0.1870 Acquired 375200 Direct
2019-11-08 Common Stock, par value $0.01 P 15000 $0.1700 Acquired 390200 Direct
2019-11-08 Common Stock, par value $0.01 P 14800 $0.1780 Acquired 405000 Direct
2019-11-08 Common Stock, par value $0.01 P 10000 $0.1740 Acquired 415000 Direct
2019-11-08 Common Stock, par value $0.01 P 10000 $0.1880 Acquired 425000 Direct